103 related articles for article (PubMed ID: 24845969)
1. Controversial constitutive TSHR activity: patients, physiology, and in vitro characterization.
Huth S; Jaeschke H; Schaarschmidt J; Paschke R
Horm Metab Res; 2014 Jun; 46(7):453-61. PubMed ID: 24845969
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activities in the thyrotropin receptor: regulation and significance.
Kleinau G; Biebermann H
Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
[TBL] [Abstract][Full Text] [Related]
3. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
4. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
5. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6.
Winkler F; Kleinau G; Tarnow P; Rediger A; Grohmann L; Gaetjens I; Krause G; L'Allemand D; Grüters A; Krude H; Biebermann H
J Clin Endocrinol Metab; 2010 Aug; 95(8):3605-10. PubMed ID: 20501679
[TBL] [Abstract][Full Text] [Related]
6. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
7. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G
J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
[TBL] [Abstract][Full Text] [Related]
9. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
[TBL] [Abstract][Full Text] [Related]
10. A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7.
Jaeschke H; Schaarschmidt J; Eszlinger M; Huth S; Puttinger R; Rittinger O; Meiler J; Paschke R
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2051-9. PubMed ID: 24947036
[TBL] [Abstract][Full Text] [Related]
11. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
Lado-Abeal J; Quisenberry LR; Castro-Piedras I
Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
[TBL] [Abstract][Full Text] [Related]
12. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
Führer D; Wonerow P; Willgerodt H; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor-associated diseases: from adenomata to Graves disease.
Davies TF; Ando T; Lin RY; Tomer Y; Latif R
J Clin Invest; 2005 Aug; 115(8):1972-83. PubMed ID: 16075037
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.
Liu Z; Fan F; Xiao X; Sun Y
PLoS One; 2011 Jan; 6(1):e16335. PubMed ID: 21283701
[TBL] [Abstract][Full Text] [Related]
16. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation.
Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R
Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076
[TBL] [Abstract][Full Text] [Related]
17. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism and Papillary Thyroid Carcinoma in Thyrotropin Receptor D633H Mutant Mice.
Jaeschke H; Undeutsch H; Patyra K; Löf C; Eszlinger M; Khalil M; Jännäri M; Makkonen K; Toppari J; Zhang FP; Poutanen M; Paschke R; Kero J
Thyroid; 2018 Oct; 28(10):1372-1386. PubMed ID: 30132406
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
Wonerow P; Neumann S; Gudermann T; Paschke R
J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]